Montelukast Sodium
Product Images NDC 55111-763

5 FDA label images from Dr.reddy's Laboratories Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 55111-763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
Montelukast Sodium Oral Granules, 4 mg, unit dose carton of 30 packets for pediatric patients 6 months to 5 years of age. The packaging shows instructions for use, storage conditions, barcode, and manufacturing details by Dr. Reddy's Laboratories Limited, India. It includes a directive for pharmacists to dispense the patient information leaflet with the product.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph depicting change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo. The x-axis shows weeks on treatment from -20 to 56, and the y-axis shows height change from -2 to 7 cm, illustrating longitudinal growth trends for each treatment group.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
Line graph showing mean percent change from baseline over weeks in treatment for Montelukast Sodium compared to placebo. The x-axis represents weeks in treatment from 0 to 15, including washout period, and the y-axis shows mean percent change from baseline ranging from 0 to 15. Montelukast Sodium data are marked with filled circles, placebo with open squares.*
FDA Label Image

Packetlabel (Packetlabel)

Packetlabel (Packetlabel)
Montelukast Sodium 4 mg oral granules packaging label by Dr. Reddy's Laboratories Limited. The product is intended for pediatric patients 6 months to 5 years of age, each packet contains 4 mg Montelukast USP equivalent. The label includes directions for use, storage instructions specifying room temperature, and a barcode. Manufactured in India, the label displays the NDC 55111-763-07.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Montelukast Sodium showing its molecular framework including chlorine, sulfur, and sodium groups as depicted in the image provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.